Wasatch Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
TGY2IT
Wasatch Advisors's VKTX Position: Q3 2026 in Review
Wasatch Advisors reduced its Viking Therapeutics (VKTX) stake by 37% in Q3 2026, selling an estimated $3.97M and leaving 198,136 shares worth $6.46M. The position accounts for 0.05% of the portfolio, ranked #160.
Wasatch Advisors first reported a position in VKTX in Q1 2023 and has held it in 15 quarters since. The position peaked at $28.4M in Q1 2023. 71 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Wasatch Advisors held 198,136 shares of Viking Therapeutics worth $6.46M as of Q3 2026.
- Wasatch Advisors sold 114,631 Viking Therapeutics shares in Q3 2026, an estimated $3.97M.
- Viking Therapeutics made up 0.05% of Wasatch Advisors's portfolio in Q3 2026, its #160 holding.
- Wasatch Advisors first reported a position in Viking Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Wasatch Advisors's Viking Therapeutics position peaked at $28.4M in Q1 2023.
- 71 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Wasatch Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.